Clinical features and outcomes of thoracic surgery patients during the COVID-19 pandemic

Jiménez, María Salmerón; Alarza, Fátima Hermoso; Serna, Iván Martínez; Fernández, Carmen Jiménez; Pardo, José Carlos Meneses; Salcedo, José Alberto García; Serna, Alejandro Torres; Gama, Mario Gustavo Manama; Mendoza, Oscar Enrique Colmenares; Gude, V. Díaz-Hellín; García, Antonio Pablo Gámez

doi:10.1093/ejcts/ezaa287

Cited by 7 publications

(6 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…These guidelines, together with the use of COVID-19-free areas of the hospital, were particularly important in Spain, in which the high incidence of SARS-CoV-2 and consequent hospital overload had a major impact on surgical procedures. Importantly, this strategy allowed for the surgical treatment of selected patients with little to no excess morbidity and mortality [18,19].…”

Section: Introductionmentioning

confidence: 99%

Effect of COVID-19 on Thoracic Oncology Surgery in Spain: A Spanish Thoracic Surgery Society (SECT) Survey

Martínez-Hernández

Silva

Cabañero-Sánchez

et al. 2021

Cancers

View full text Add to dashboard Cite

After the first wave of COVID-19, the Spanish Society of Thoracic Surgeons (SECT) surveyed its members to assess the impact of the pandemic on thoracic oncology surgery in Spain. In May 2020, all SECT members were invited to complete an online, 40-item, multiple choice questionnaire. The questionnaire was developed by the SECT Scientific Committee and sent via email. The overall response rate was 19.2%. The respondents answered at least 91.5% of the items, with only one exception (a question about residents). Most respondents (89.3%) worked in public hospitals. The reported impact of the pandemic on routine clinical activity was considered extreme or severe by 75.5% of respondents (25.5% and 50%, respectively). Multidisciplinary tumour boards were held either with fewer members attending or through electronic platforms (44.6% and 35.9%, respectively). Surgical activity decreased by 95.7%, with 41.5% of centers performing surgery only on oncological patients and 11.7% only in emergencies. Nearly 60% of respondents reported modifying standard protocols for early-stage cancer and in the preoperative workup. Most centers (≈80%) reported using full personal protective equipment when operating on COVID-19 positive patients. The COVID-19 pandemic severely affected thoracic oncology surgery in Spain. The lack of common protocols led to a variable care delivery to lung cancer patients.

show abstract

Section: Introductionmentioning

confidence: 99%

Effect of COVID-19 on Thoracic Oncology Surgery in Spain: A Spanish Thoracic Surgery Society (SECT) Survey

Martínez-Hernández

Silva

Cabañero-Sánchez

et al. 2021

Cancers

View full text Add to dashboard Cite

show abstract

“…Similar approaches to prioritize patients undergoing cardiac surgery and their preoperative screening for COVID-19 have also been recommended, Keskin et al, developed a different screening system to decide when to postpone or proceed with elective cardiac or vascular interventions based on a checklist containing relevant symptoms and signs of the disease, history of traveling or patient contact to determine the risk of COVID-19 transmission. [11][12][13] Our study showed that elective cardiovascular surgery procedures could be performed with acceptable mortality rates. Although our mortality rate was 9% during the study period, this result must be interpreted with caution because none of those patients had an elective procedure, in addition, their euroscores were relatively high, two patients who underwent urgent CABG had poor left ventricular function and died with low cardiac output syndrome, the patient who underwent open repair of ruptured AAA died due to acute renal failure, the patient with TVR died also due to renal failure and severe thrombocytopenia which leads to cerebral and massive gastrointestinal system hemorrhage, the remaining two patients died intraoperatively, one had fragile aorta which ruptured after the cross-clamp was removed, the other one was the patient with post-MI VSD, the last two patients who also underwent urgent CABG procedure, died due to postoperative COVID-19 infection.…”

Section: Discussionmentioning

confidence: 63%

Adult Cardiovascular Surgery During COVID-19 Pandemic: A Retrospective Single Center Experience

ALAGHA¹,

ÇİÇEKÇİOĞLU²,

Ekim³

et al. 2022

Turkiye Klinikleri J Cardiovasc Sci

View full text Add to dashboard Cite

Coronavirus disease-2019 (COVID-19), caused by a novel coronavirus, has become a worldwide pandemic. In order to control the global spread of this contagious disease, elective surgeries including cardiac and vascular procedures were postponed. In this article we present our experience during the initial phase of the pandemic in view of safety protocols. Material and Methods:The study included all elective, urgent, and emergent procedures that were performed from March 11, 2020 to June 30, 2021 at the department of cardiovascular surgery. Patients' demographics, preoperative COVID-19 (reverse transcription-polymerase chain reaction) test results, surgical procedures, complications and outcomes were prospectively collected. We also developed our own protocol to proceed with our surgical activity without delay. Results: A total of 86 cardiac and vascular procedures were performed during the study period. The median age was 64 years (range 23-79), 59 (69%) were males. There were 42 (48%) elective procedures, and 13 (15%) patients had emergency procedures. 57 (66%) patients underwent coronary artery bypass graft surgery. 10 (12%) patients underwent valvular procedures. Peripheral vascular surgeries were performed in 18 (21%) patients. The median length of stay in the hospital was 9 days (range 1-60). A positive COVID-19 test was identified in 4 patients, two of them were detected in the immediate postoperative period and died. In-hospital mortality was 9%. Conclusion: Cardiovascular procedures could be performed safely with a relatively low risk during the outbreak, particularly for elective patients with proper management and strict infection control and isolation protocols.

show abstract

“…Adequate use of personal protective equipment (PPE) during aerosol-generating procedures (AGPs), such as endotracheal intubation and airway surgical or endoscopic procedures, and a COVID-19 specifc intraoperative management are paramount in order to prevent cross infections [16]. Although guidelines have been published for the management of surgical patients during the SARS-CoV-2 pandemic, so far, few studies of surgical patients have been reported, and little is known about preoperative routine screening for SARS-CoV-2 infection among surgical patients [4,17].…”

Section: Discussionmentioning

confidence: 99%

Preoperative SARS-CoV-2 Infection Screening before Thoracic Surgery during COVID-19 Pandemic: A Multicenter Retrospective Study

Fiorelli

Menna

Piccioni

et al. 2023

International Journal of Clinical Practice

View full text Add to dashboard Cite

Objectives. During coronavirus disease (COVID-19) pandemic, preoperative screening before thoracic surgery is paramount in order to protect patients and staff from undetected infections. This study aimed to determine which preoperative COVID-19 screening tool was the most effective strategy before thoracic surgery. Methods. This retrospective cohort multicenter study was performed at 3 Italian thoracic surgery centers. All adult patients scheduled for thoracic surgery procedures from 4th March until 24th April, 2020, and submitted to COVID-19 preoperative screenings were included. The primary outcome was the yield of screening of the different strategies. Results. A total of 430 screenings were performed on 275 patients; 275 anamnestic questionnaires were administered. 77 patients were screened by an anamnestic questionnaire and reverse transcriptase polymerase chain reaction (RT-PCR). 78 patients were selected to combine screening with anamnestic questionnaire and chest computed tomography (CT). The positive yield of screening using a combination of anamnestic questionnaire and RT-PCR was 7.8% (95% CI: 2.6–14.3), while using a combination of anamnestic questionnaire and chest CT was 3.8% (95% CI: 0–9). Individual yields were 1.1% (95% CI: 0–2.5) for anamnestic questionnaire, 5.2% (95% CI: 1.3–11.7) for RT-PCR, and 3.8% (95% CI: 0–9). Conclusions. The association of anamnestic questionnaire and RT-PCR is able to detect around 8 positives in 100 asymptomatic patients. This combined strategy could be a valuable preoperative SARS-CoV-2 screening tool before thoracic surgery.

show abstract

Clinical features and outcomes of thoracic surgery patients during the COVID-19 pandemic

Cited by 7 publications

References 18 publications

Effect of COVID-19 on Thoracic Oncology Surgery in Spain: A Spanish Thoracic Surgery Society (SECT) Survey

Effect of COVID-19 on Thoracic Oncology Surgery in Spain: A Spanish Thoracic Surgery Society (SECT) Survey

Adult Cardiovascular Surgery During COVID-19 Pandemic: A Retrospective Single Center Experience

Preoperative SARS-CoV-2 Infection Screening before Thoracic Surgery during COVID-19 Pandemic: A Multicenter Retrospective Study

Contact Info

Product

Resources

About